By proceeding, you agree to our Terms of Use and Privacy Policy.
ProPharma Group is the global, independent, single-source provider of regulatory and compliance consulting, clinical research services, pharmacovigilance, and medical information serving pharmaceutical, biotechnology, and medical device companies.
04-05 May 2022
In today’s fast changing and unforeseeable times, pharmaceutical companies need to follow a wide range of processes and stick to the majority of regulations, in order to ensure their pharmacovigilance is up to standards. But how to be in charge of th
Event Ended
Austria
Paid
Vienna
27-29 September 2022
Europe’s Most Exciting Drug Safety & PV Event The World Drug Safety Congress Europe is empowering patients, physicians, pharma, biotech and consumers to make the best drug safety decisions. We’ll bring together 600+ key thought leaders to explore the
Hybrid
Amsterdam
25-27 October 2022
Welcome to the 6th Annual Gene Therapy for Rare Disorders Europe Summit 2022 Gain European Regulatory Clarity to Progress Efficient & Robust Gene Therapies for Rare Disease As more and more companies gear up for clinical activity and near approval de
UK
London
10-10 January 2023
A multi-year pandemic has brought new challenges for pharma and healthcare, but also plenty of triumphs and opportunities for innovation.
USA
San Francisco
17-19 January 2023
Virtual
Free
21-23 February 2023
Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to ma
23-25 May 2023
Join us at the Gaylord National Resort & Convention Center in Washington, D.C. from May 23-25, 2023 for the world's most important orphan drug and rare disease event. With over 1,200 attendees, 100+ sponsors and exhibitors, 250+ speakers, and 13 them
National Harbor
21-22 August 2023
The 8th annual Liquid Biopsy for Disease Management: From Discovery to Clinical Use conference will review new liquid biopsies coming on the market that have increased sensitivity and are robust enough for clinical applications for measuring treatmen
Washington, DC
The point-of-care industry is poised for tremendous growth and is fueled by both the explosion of enabling technologies as well as the huge need for disruption in the medical sector as consumers demand flexibility and access to testing as well as fas
Development of companion diagnostics shows no signs of slowing down anytime soon. As the field continues to grow, it is critical that the surrounding landscape progresses with it. Partnerships between pharmaceutical and diagnostic companies can lead
22-23 August 2023
The increase in testing and demands of the COVID-19 pandemic has spurred tremendous innovation for infectious disease testing platforms that reduce time, cost, and offer greater access than ever before. At the 15th Annual Advanced Diagnostics for Inf
As diagnostics become increasingly complex, coverage and reimbursement come to the forefront of challenges that diagnostic companies face. Deep understanding of how policy is developed and implemented and how policy will change over time will provide
Current guidelines call for screening for only five types of cancer, and in each case for one type of cancer per screen. This means that there are no screening tests available for the majority of cancers, and far too often cancer is only detected onc
Within the last few years, we saw a seismic global shift in the acceptance and availability of point-of-care and home-based testing, bolstered by a heightened interest in and capability for decentralized processes. Healthcare systems and providers we
18-21 September 2023
Join us at the Cell & Gene Therapy Manufacturing & Commercialization US 2023, the premier event dedicated to revolutionizing the field of cell and gene therapy manufacturing, commercialization, and supply chain strategies. As the leading conference i
Boston